We show that the landscape of recurrent glioblastoma is unique, wherein tumours display increased EGFR pathway expression without evidence of EGFR amplification, suggesting a phenotypic change not captured at the level of EGFR copy number or EGFR mRNA expression, arguing for an alternative mechanism for increased pathway activity. The gene discussed is EGFR; the disease is neoplasm.